$0.32 EPS Expected for Innoviva Inc (INVA)

October 10, 2017 - By Darrin Black

 $0.32 EPS Expected for Innoviva Inc (INVA)

Wall Street await Innoviva Inc (NASDAQ:INVA) to release earnings on October, 26. Analysts forecast earnings per share of $0.32, up exactly $0.16 or 100.00 % from 2014’s $0.16 EPS. The expected INVA’s profit could reach $35.03 million giving the stock 11.06 P/E in the case that $0.32 earnings per share is reported. After posting $0.30 EPS for the previous quarter, Innoviva Inc’s analysts now forecast 6.67 % EPS growth. The stock decreased 1.12% or $0.16 during the last trading session, reaching $14.16. About 497,575 shares traded. Innoviva Inc (NASDAQ:INVA) has risen 9.71% since October 10, 2016 and is uptrending. It has underperformed by 6.99% the S&P500.

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. The company has market cap of $1.55 billion. It focuses on the respiratory assets partnered with Glaxo Group Limited , including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It has a 19.78 P/E ratio. Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement and the Strategic Alliance Agreement with GSK, the Company is eligible to receive the annual royalties from GSK on sales of RELVAR/BREO ELLIPTA.

More important recent Innoviva Inc (NASDAQ:INVA) news were published by: Streetinsider.com which released: “Theravance Biopharma (TBPH) Highlights GlaxoSmithKline and Innoviva’s Receipt …” on September 18, 2017, also Prnewswire.com published article titled: “Breakfast Technical Briefing on Application Software Stocks — FireEye …”, Businesswire.com published: “GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing …” on September 20, 2017. More interesting news about Innoviva Inc (NASDAQ:INVA) was released by: Businesswire.com and their article: “Innoviva to Participate in Cantor Fitzgerald’s Global Healthcare Conference on …” with publication date: September 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com